| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |